Cross-fund · 5 holders
HALO
HALOZYME THERAPEUTICS INC
CUSIP 40637H109
5
Tracked holders
$1.72B
Aggregate value
26,096,513
Shares
5
Active funds
Funds holding HALO
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $857.3M | 0.01% | +111,196 | +0.8% |
| Vanguard | Institutional | Q4 2025 | $778.5M | 0.01% | -62,890 | -0.5% |
| BridgewaterFEAT | Macro | Q1 2026 | $33.1M | 0.15% | -50,148 | -8.9% |
| Millennium | Multi-Strategy | Q1 2026 | $30.5M | 0.01% | -1,042,664 | -68.9% |
| Citadel | Multi-Strategy | Q1 2026 | $18.2M | — | +245,951 | +685.1% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.